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Single-use-technologies (SUT) are a category of disposable bioprocessing components which have 
increased in popularity in the biopharmaceutical industry in recent years [1]. Stirred single use 
bioreactors use a polymeric bag supported by a rigid metal frame. The bag is disposed of and 
replaced after use, removing the need for energy-intensive and time consuming cleaning and 
sterilisation in place, as well as improving the flexibility of the production facility [2]. They are 
currently applied mainly to the production of vaccines by mammalian cell cultures [3] due to the low 
shear and oxygen requirements when compared to industrial fermentation processes.  
 
This work is part of a PhD project which aims to produce a validated CFD model of multiphase gas-
liquid mixing in a cubic SUT bioreactor. This geometry is preferred due to the high bag integrity and 
simplicity over existing cylindrical SUT bioreactors. A magnetically-driven floor mounted impeller is 
also included in order to further simplify the geometry and allow for the close stacking of multiple 
bags. Multiphase modelling in a 1 m3 vessel has been performed using the commercial software 
ANSYS CFX at a range of stirrer speeds and gas flow-rates in an attempt to optimise conditions in the 
reactor for oxygen mass transfer. Turbulence is modelled using the k-ε model, with impeller motion 
modelled using the multiple reference frame method. Five different models for the mass transfer 
coefficient, kL, which are suitable for calculation from CFD derived parameters such as turbulent 
eddy dissipation and superficial gas velocity, are compared. An optimum stirrer speed of 400 RPM 
was identified, above which the mass transfer - characterised by kLa values - is not improved despite 
the additional power input. A proposed 200 L variation of this cubic design was also investigated, 
showing significantly improved gas mass transfer. 
 
Validation of the models is performed in a separate lab-scale cubic glass tank, with point velocity 
measurements taken using two-dimensional Laser Doppler Anemometry (LDA). These 
measurements are combined to create profiles within the vessel which are compared to a CFD 
model of the same geometry. Three impeller types are used for the validation experiments; a six-
bladed Rushton impeller, a four-bladed radial impeller and a four-bladed axial impeller. Validation 
experiments are currently performed in single-phase, however the process will be expanded to 
cover multiphase gas-liquid systems including both liquid-phase velocity and bubble size distribution 
measurements. A good agreement is observed between the modelled and experimental profiles in-
line with the impeller, in particular the swirling flow patterns characterised by the tangential 
velocity.  
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